GABA-T Scramble control ASO
GABA-T Scramble control ASO is a scrambled control antisense oligonucleotide with no complementarity to known genes. GABA-T Scramble control ASO can be used as a negative control for in vivo GABA-T (ABAT) knockdown to demonstrate the specificity of target reduction. GABA-T Scramble control ASO can be used in research related to metabolic diseases such as obesity, type 2 diabetes, and non-alcoholic fatty liver disease.
For research use only. We do not sell to patients.
-
Storage:
-20°C, sealed storage, away from moisture
* In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture)
All DNA/RNA Synthesis Isoforms
More
Biological Activity
Description
In Vivo
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Animal Model:C57BL/6J (male, 20-26 weeks, diet-induced obesity)[1]
-
Dosage:12.5 mg/kg
-
Administration:i.p.; twice weekly; 1 or 4 weeks
-
Result:Did not alter pancreatic or whole-brain GABA-T mRNA expression.
Did not affect body weight or glucoregulatory measures in lean mice.
Did not affect food intake or relative weight change following leptin injection in obese mice.
Chemical Information
-
Appearance Solid
-
SMILES
[GABA-T Scramble control ASO]
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
-20°C, sealed storage, away from moisture
* In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture)
Protocols
-
RNA interference technology
RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing gene transcription or activating RNA degradation. This mechanism was discovered in plants in 1998 by Andrew Fire and Craig Mello. Today, this phenomenon can be observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals.
-
Research Protocol for Metabolic Diseases
AMP-activated protein kinase, AMPK, is a conserved cellular energy sensor that responds to reduced cellular energy status and coordinates metabolism by increasing ATP-generating catabolic pathways while suppressing ATP-consuming anabolic processes. In metabolic disease research, the AMPK pathway is experimentally relevant because it regulates hepatic lipid synthesis, fatty acid oxidation, glucose production, skeletal-muscle glucose disposal, mTORC1-linked biosynthesis, autophagy, mitochondrial homeostasis, and whole-body energy balance. The central pathway logic is that energy stress, metformin, exercise-like stimulation, or direct AMPK activators increase AMPKα Thr172 phosphorylation and downstream substrate phosphorylation, including ACC and RAPTOR. Phosphorylation of ACC suppresses lipogenesis and supports fatty acid oxidation, whereas phosphorylation of RAPTOR suppresses mTORC1 signaling and links cellular energy status to growth and protein synthesis control. The pathway is linked
Purity & Documentation
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)